Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Robot-Compatible Automatic Dry Down Station
Tuesday, September 10, 2013
Porvair will launch UltraVap Mistral at Biotechnica 2013.

Faster Drying of Deep Well Microplates
Tuesday, September 10, 2013
New generation heat transfer plates from Genevac.

Large Volume Plates for Storage / Transport Applications
Thursday, August 22, 2013
Available in sterile or non-sterile versions.

Highly Affordable Lab Safety Shield
Wednesday, August 21, 2013
Provides protection for chemists from draughts, splashes, aerosols and spills.

Evaporation Chemistry at ACS
Monday, August 19, 2013
Genevac to display its latest products for productive evaporation in USA.

Huber Presents the 4 Aces of Temperature Control!
Thursday, August 15, 2013
Huber has a winning hand with a suite of very compact, high efficiency and low-cost products.

Thermo Fisher Scientific Expands Water Purification Portfolio
Thursday, August 01, 2013
Advanced dispensing technology increases flexibility and ease-of-use for shared lab environments.

Thermo Fisher Scientific Showcases New Small Benchtop Centrifuge at AACC
Thursday, August 01, 2013
Provides scientists with outstanding capacity in a compact design.

ChanTest Announces ChansPorter™ Assays to Accelerate Drug Development
Monday, July 22, 2013
ChansPorter™ Assays provide the best means possible for measuring the functional activity of important pharmaceutical targets, including the Cystic Fibrosis Transmembrane conductance Regulator (CFTR).

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1259
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv